Oregon Public Employees Retirement Fund’s iTeos Therapeutics ITOS Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,915	Closed	-$86.7K	–	1559
2023 Q3	$86.7K	Buy	7,915 +200	+3%	+$2.56K	﹤0.01%	1663
2023 Q2	$102K	Sell	7,715 -400	-5%	-$5.7K	﹤0.01%	1677
2023 Q1	$110K	Sell	8,115 -20	-0.2%	-$358	﹤0.01%	1663
2022 Q4	$159K	Sell	8,135 -14	-0.2%	-$274	﹤0.01%	1626
2022 Q3	$155K	Buy	8,149 +1,500	+23%	+$34.6K	﹤0.01%	1603
2022 Q2	$137K	Sell	6,649 -900	-12%	-$21.4K	﹤0.01%	1481
2022 Q1	$243K	Buy	+7,549	New	+$274K	﹤0.01%	1587

Other funds holding ITOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Oregon Public Employees Retirement Fund's ITOS Position: Q4 2023 in Review

Oregon Public Employees Retirement Fund sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 7,915 shares — an estimated $86.7K sold.

Oregon Public Employees Retirement Fund first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $243K in Q1 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

Oregon Public Employees Retirement Fund reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 7,915 iTeos Therapeutics shares in Q4 2023, an estimated $86.7K.
Oregon Public Employees Retirement Fund first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
Oregon Public Employees Retirement Fund's iTeos Therapeutics position peaked at $243K in Q1 2022.
138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q4 2023, filed 12 Feb 2024.